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the risks. Ultimately, the decision to 
continue or discontinue the use of a 
medical device when localised skin 
symptoms occur has to be made in 
consultation with the patient.
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which might be contributing factors to 
adverse events.4,5 Sensor-wear-related 
symptoms were recorded as adverse 
events in the IMPACT trial if the effects 
were severe and lasted for more than 
7 days, or if the patient required 
prescription medication for the event 
to resolve. Adverse event severities 
were recorded on the basis of a health-
care professionals assessment of mild, 
moderate, or severe events.
According to the study protocol, 
individuals with known sensitivity 
to medical-grade adhesives were 
excluded from participation. However, 
we reasonably expected that a few 
participants might have been unaware 
of their sensitivity until they had 
exposure to the product for longer 
than a few days. For participants 
with adverse events involving skin 
symptoms during this trial, symptoms 
(including severe) were resolved by use 
of barrier products (eg, Cavilon spray) 
or drug therapy (eg, zinc ointment, 
Fenistil gel, or hydrocortisone 
cream) as prescribed, or simply by 
relocating the device to another area 
of the skin such that the effects were 
maintained at a tolerable, background 
level. In other cases, although the 
adverse events were generally mild 
or moderate, the longevity of the 
symptoms, despite use of treatment, 
contributed to the participant’s 
decision to withdraw from the trial. 
None of the participants withdrew 
because of health-care professional 
advice to stop wearing the sensor.
Since completion of the IMPACT 
trial, minor design changes have been 
made to FreeStyle Libre. These changes 
are expected to improve breathability 
of the skin that is in contact with the 
sensor and to facilitate the exclusion 
of moisture between the sensor–skin 
interface.
We conclude that although some 
individuals might be intolerant to using 
devices with medical-grade adhesive, 
others might have manageable skin 
symptoms from sensor wear. Overall, 
we believe that the benefits of using 
such a system generally outweigh 
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physicians. The authors additionally 
warned against confusing burnout 
with depression. We are concerned 
with the validity of these conclusions.
First, there is now robust evidence 
that burnout is a depressive condition.2,3 
The misunderstanding surrounding 
burnout–depression overlap might 
reflect both a neglect of the stress–
depression association and a difficulty 
coordinating dimensional and 
categorical approaches to depression in 
burnout research. The issue is not about 
interchanging one term with the other. 
By cultivating the idea that burnout 
is not a depressive condition, despite 
evidence to the contrary, investigators 
inhibit themselves from exploiting the 
accumulated knowledge on treating and 
preventing (job-induced) depression 
when helping sufferers of burnout.
Second, the published estimates of 
burnout’s prevalence rely on clinically 
groundless criteria, cobbled together 
without any rationale.4 In one study,5 
depending on how burnout was 
identified, the prevalence of burnout 
went from 69% to 10%, showing 
a worrying malleability. Because 
estimates of prevalence of burnout 
do not have a nosological frame and 
are adjustable at convenience, they 
can be easily challenged by anyone 
willing to discourage public health 
initiatives intended to enhance working 
conditions and alleviate job stress. 
Recognising burnout–depression 
overlap would help resolve the problem. 
By contrast to burnout, depression, in 
its different forms, is diagnosable in a 
consensual and clinically valid way.
Promoting occupational health is a 
difficult job. The major organisational 
changes recommended by Epstein and 
Privitera1 are unlikely to be implemented 
without resistance. Switching from a 
the construct of burnout to depression 
would strengthen research validity and 
public health decision-making authority.
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major depression, workers often 
have one without the other. Maslach 
and colleagues, addressed this issue 
early in development of the burnout 
construct and assessment scale4 and 
again recently.1 Appropriately, burnout 
is conceptualised as a breakdown in 
the relationship between people and 
their work. That burnout has worsened 
acutely in the context of radical changes 
in the nature of clinical work—electronic 
health records that reduce face-to-face 
time and documentation mandates 
that have exponentially increased the 
burden of meaningless tasks—speaks 
against a purely individual syndrome.
Pragmatically speaking, considering 
burnout solely as a mental illness of 
individual workers rather than work-
related distress would be disastrous in 
the US context and perhaps elsewhere. 
Many US institutions and medical 
boards require that physicians report 
any history of mental illness when 
applying for a medical licence and 
hospital privileges, an unfortunate 
reality. Physicians will be more willing 
to accept that they are burned out and 
seek help if they feel that they will not 
be stigmatised for what they see as a 
systemic or institutional problem. In 
March, 2016, Vivek Murthy, the US 
Surgeon General, declared that burnout 
among health-care workers was one of 
the two most pressing health problems 
in the nation to be addressed during the 
subsequent year. It is our hope that we 
will continue to clarify the conceptual 
and measurement issues while moving 
forward quickly to alleviate a pressing 
national—and global—problem.
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Authors’ reply
We agree with Renzo Bianchi and 
colleagues that the public health 
significance of job-related distress 
is large—and costly in both human 
and financial terms1—and that the 
variability of definitions and thresholds 
for burnout in the literature have been 
problematic. West and colleagues’ 
review in The Lancet2 addressed that 
issue partly by using one definition of 
burnout (high emotional exhaustion or 
depersonalisation) and also supplying 
data on individual domains and 
numerical Maslach burnout inventory 
scale scores. Importantly, these scores, 
taken as continuous or dichotomous 
variables, have been clearly linked with 
clinically relevant outcomes and are 
responsive to both institutional and 
individual interventions. Although 
there is still a need for conceptual 
clarification now that physician 
distress is finally recognised as a serious 
problem, discarding the construct of 
burnout altogether seems unwarranted.
Recognition of major depression 
is important. We do not agree, 
however, that there is robust evidence 
that burnout is merely depression.3 
Although there is substantial overlap 
between the two conditions, and 
physicians with the highest amount 
of burnout are more likely to develop 
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